X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-11-16 | ACHR | Archer Aviation Inc. | Gupta Priya | Interim CFO | S - Sale+OE | $3.69 | -11,474 | 211,708 | -5% | -$42,385 | |||||
| D | 2026-11-16 | ACHR | Archer Aviation Inc. | Lentell Eric | Chief Strategy Officer | S - Sale+OE | $3.69 | -43,066 | 119,521 | -26% | -$159,086 | |||||
| D | 2026-11-16 | ACHR | Archer Aviation Inc. | Lyon Benjamin | Pres, Aircraft OEM | S - Sale+OE | $3.69 | -53,039 | 42,508 | -56% | -$195,926 | |||||
| D | 2026-11-16 | ACHR | Archer Aviation Inc. | Rungta Harsh | Chief Accounting Officer | S - Sale+OE | $3.69 | -14,669 | 130,344 | -10% | -$54,187 | |||||
2026-11-17 | AIRG | Airgain Inc | Elbaz Michael | CFO | S - Sale | $3.78 | -4,461 | 131,045 | -3% | -$16,884 | ||||||
2026-10-21 | ALLO | Allogene Therapeutics, Inc. | Parker Geoffrey M. | CFO | S - Sale | $1.34 | -36,342 | 1,045,877 | -3% | -$48,698 | ||||||
2026-11-05 | ANTX | An2 Therapeutics, Inc. | Eizen Joshua M | See Remarks | S - Sale | $4.22 | -2,826 | 207,546 | -1% | -$11,926 | ||||||
2026-11-02 | ARTV | Artiva Biotherapeutics, Inc. | Aslan Fred | CEO | S - Sale | $4.18 | -62,178 | 1,457,428 | -4% | -$259,972 | ||||||
2026-11-02 | ARTV | Artiva Biotherapeutics, Inc. | Horan Christopher | Chief Tech Operations Officer | S - Sale | $4.18 | -10,423 | 302,321 | -3% | -$43,580 | ||||||
2026-11-02 | ARTV | Artiva Biotherapeutics, Inc. | Bush Jennifer | COO, CLO, Compliance Officer | S - Sale | $4.18 | -8,439 | 357,720 | -2% | -$35,284 | ||||||
2026-11-17 | ARTV | Artiva Biotherapeutics, Inc. | Aslan Fred | CEO | S - Sale | $3.91 | -119,771 | 1,337,657 | -8% | -$468,532 | ||||||
2026-11-17 | ARTV | Artiva Biotherapeutics, Inc. | Banerjee Subhashis | Chief Medical Officer | S - Sale | $3.91 | -4,037 | 164,701 | -2% | -$15,792 | ||||||
2026-11-17 | ARTV | Artiva Biotherapeutics, Inc. | Horan Christopher | Chief Tech Operations Officer | S - Sale | $3.91 | -20,546 | 281,775 | -7% | -$80,374 | ||||||
2026-11-17 | ARTV | Artiva Biotherapeutics, Inc. | Bush Jennifer | COO, CLO, Compliance Officer | S - Sale | $3.91 | -19,217 | 338,503 | -5% | -$75,175 | ||||||
2026-10-16 | ASPI | Asp Isotopes Inc. | Kiessling Heather | CFO | S - Sale | $2.19 | -21,830 | 1,504,422 | -1% | -$47,808 | ||||||
2026-10-20 | BIOF | Blue Biofuels, Inc. | Kneppers Chris J | Dir | S - Sale | $0.10 | -125,510 | 19,747,167 | -1% | -$12,551 | ||||||
| M | 2026-10-28 | BIOF | Blue Biofuels, Inc. | Kneppers Chris J | Dir | S - Sale | $0.10 | -452,000 | 19,295,167 | -2% | -$47,220 | |||||
2026-10-19 | BLND | Blend Labs, Inc. | Ghamsari Nima | HEAD OF BLEND | S - Sale | $0.92 | -27,775 | 7,750,693 | 0% | -$25,664 | ||||||
2026-10-26 | BLND | Blend Labs, Inc. | Ghamsari Nima | HEAD OF BLEND | S - Sale | $1.12 | -21,368 | 7,729,325 | 0% | -$23,911 | ||||||
2026-11-02 | BLND | Blend Labs, Inc. | Ghamsari Nima | HEAD OF BLEND | S - Sale | $1.16 | -22,322 | 7,707,003 | 0% | -$25,782 | ||||||
2026-11-09 | BLND | Blend Labs, Inc. | Ghamsari Nima | HEAD OF BLEND | S - Sale | $0.97 | -25,511 | 7,681,492 | 0% | -$24,618 | ||||||
2026-11-16 | BLND | Blend Labs, Inc. | Ghamsari Nima | HEAD OF BLEND | S - Sale | $1.03 | -23,365 | 7,658,127 | 0% | -$23,949 | ||||||
2026-11-16 | BRLT | Brilliant Earth Group, Inc. | Dziesietnik Sharon | Chief Operations Officer | S - Sale | $1.15 | -9,511 | 522,937 | -2% | -$10,938 | ||||||
2026-11-12 | CCCC | C4 Therapeutics, Inc. | Adams Kendra | CFO | S - Sale | $2.71 | -45,173 | 337,150 | -12% | -$122,487 | ||||||
2026-11-16 | CDXS | Codexis, Inc. | Moore Alison | Pres, CEO | S - Sale | $1.14 | -10,651 | 233,520 | -4% | -$12,111 | ||||||
| M | 2026-09-15 | CIRC | Circle8 Group Inc | Franke Guus Paul Wilhelm | CEO | S - Sale | $0.42 | -819,359 | 11,387,928 | -7% | -$341,753 | |||||
2026-11-10 | CLNE | Clean Energy Fuels Corp. | Littlefair Andrew J | Dir | S - Sale | $1.84 | -100,000 | 1,882,832 | -5% | -$183,910 | ||||||
2026-10-19 | CLOV | Clover Health Investments, Corp. /De | Reynoso Jamie L. | CEO, Medicare Advantage | S - Sale | $4.41 | -4,066 | 2,770,351 | 0% | -$17,931 | ||||||
2026-10-20 | CLOV | Clover Health Investments, Corp. /De | Soares Karen | GC | S - Sale | $4.66 | -19,275 | 1,573,423 | -1% | -$89,822 | ||||||
2026-11-16 | CLOV | Clover Health Investments, Corp. /De | Thornton Joseph Clay | CFO | S - Sale | $4.97 | -22,099 | 1,551,783 | -1% | -$109,832 | ||||||
2026-11-02 | COUR | Coursera, Inc. | Hart Gregory M. | Pres, CEO | S - Sale | $3.59 | -10,305 | 1,528,698 | -1% | -$36,995 | ||||||
2026-10-29 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Cormorant Asset Management, LP | Former 10% Owner | S - Sale | $4.10 | -425,000 | 1,919,971 | -18% | -$1,742,755 | ||||||
| M | 2026-11-02 | CSHR | Coinshares Plc | Masters Daniel | Dir, 10% | S - Sale | $3.94 | -100,000 | 21,410,245 | 0% | -$393,621 | |||||
| DM | 2026-11-11 | CSHR | Coinshares Plc | Masters Daniel | Dir, 10% | S - Sale+OE | $3.59 | -97,914 | 21,494,701 | 0% | -$351,676 | |||||
| M | 2026-11-16 | CSHR | Coinshares Plc | Masters Daniel | Dir, 10% | S - Sale | $3.35 | -84,456 | 21,410,245 | 0% | -$283,078 | |||||
2026-10-19 | DAIC | Cid Holdco, Inc. | Lht I, LLC | 10% | S - Sale | $1.08 | -120,000 | 1,762,767 | -6% | -$129,528 | ||||||
2026-11-12 | DPU | Nexpu Ltd. | Liao Zhanlin | Dir | S - Sale | $2.11 | -37,280 | 7,401 | -83% | -$78,661 | ||||||
2026-11-12 | DPU | Nexpu Ltd. | Li Yibing | Dir | S - Sale | $2.10 | -44,628 | 0 | -100% | -$93,719 | ||||||
| D | 2026-10-27 | DRD | Drdgold Ltd | Pretorius Daniel | CEO | S - Sale+OE | $2.44 | -117,980 | 1,144,012 | -9% | -$288,025 | |||||
| D | 2026-10-27 | DRD | Drdgold Ltd | Hooijer Henriette | CFO | S - Sale+OE | $2.44 | -22,687 | 199,827 | -10% | -$55,386 | |||||
| D | 2026-10-27 | DRD | Drdgold Ltd | Gouws Henry | Head of Prod., Dir. of Ergo | S - Sale+OE | $2.44 | -89,160 | 3,050 | -97% | -$217,666 | |||||
| D | 2026-10-27 | DRD | Drdgold Ltd | Lindecke Dean | GM Ergo Ops. | S - Sale+OE | $2.44 | -48,948 | 0 | -100% | -$119,497 | |||||
| D | 2026-10-27 | DRD | Drdgold Ltd | Bornman Ryno | Financial Manager Ergo Ops. | S - Sale+OE | $2.44 | -8,388 | 16,959 | -33% | -$20,478 | |||||
| D | 2026-10-27 | DRD | Drdgold Ltd | Kruger Kevin | Head of Technical Services | S - Sale+OE | $2.44 | -73,830 | 9,240 | -89% | -$180,241 | |||||
| D | 2026-10-27 | DRD | Drdgold Ltd | Moloto Kgabo | GM FWGR Ops. | S - Sale+OE | $2.44 | -21,999 | 0 | -100% | -$53,706 | |||||
| D | 2026-10-27 | DRD | Drdgold Ltd | Laas Lihan | Financial Manager FWGR Ops. | S - Sale+OE | $2.44 | -14,787 | 0 | -100% | -$36,100 | |||||
| D | 2026-10-27 | DRD | Drdgold Ltd | Schoeman Jacobus | COO | S - Sale+OE | $2.44 | -94,575 | 70,000 | -57% | -$230,886 | |||||
| D | 2026-10-27 | DRD | Drdgold Ltd | Mashatola Mpho | Group Fin., Business Dev. Mgr | S - Sale+OE | $2.44 | -13,014 | 55,774 | -19% | -$31,771 | |||||
2026-11-11 | EDIT | Editas Medicine, Inc. | O'Neill Gilmore Neil | CEO | S - Sale | $2.42 | -21,164 | 265,592 | -7% | -$51,122 | ||||||
2026-11-11 | EDIT | Editas Medicine, Inc. | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | S - Sale | $2.42 | -7,814 | 70,379 | -10% | -$18,875 | ||||||
2026-11-05 | EGHT | 8X8 Inc /De/ | Denny Laurence | GC | S - Sale | $2.32 | -10,000 | 590,180 | -2% | -$23,202 | ||||||
2026-10-19 | ELPC | Energy Co of Parana | Sales Pedro Franco | Dir | S - Sale | $3.48 | -50,000 | 24,844 | -67% | -$173,840 | ||||||
| D | 2026-11-02 | ELVR | Elevra Lithium Ltd | Collard Sylvain | Pres Canada, Group COO | S - Sale+OE | $2.15 | -32,651 | 238,473 | -12% | -$70,174 | |||||
| M | 2026-10-30 | EMPD | Empery Digital Inc. | Brown Tice | 10% | S - Sale | $2.75 | -15,643 | 2,746,379 | -1% | -$43,000 | |||||
| D | 2026-10-29 | EOSE | Eos Energy Enterprises, Inc. | Buczkowski Michelle | Chief Commercial Officer | S - Sale+OE | $2.00 | -50,000 | 111,827 | -31% | -$100,000 | |||||
| M | 2026-11-16 | EVGO | Evgo Inc. | Kish Dennis G | Pres | S - Sale | $1.57 | -209,188 | 53,525 | -80% | -$328,066 | |||||
| AM | 2026-11-09 | EXFY | Expensify, Inc. | McLaughlin Steven J. | 10% | S - Sale | $1.77 | -557,548 | 13,429,455 | -4% | -$988,746 | |||||
| M | 2026-11-12 | EXFY | Expensify, Inc. | McLaughlin Steven J. | 10% | S - Sale | $1.83 | -360,214 | 13,069,241 | -3% | -$660,596 | |||||
2026-11-03 | EXOD | Exodus Movement, Inc. | Gernetzke James | CFO | S - Sale | $4.90 | -5,781 | 452,628 | -1% | -$28,327 | ||||||
2026-11-13 | EXOD | Exodus Movement, Inc. | Di Giacomo Gerardo | Chief Security Officer | S - Sale | $4.58 | -7,473 | 72,235 | -9% | -$34,226 | ||||||
| DM | 2026-11-13 | FAC | Factorial Energy Inc. | Scuteri Jeffrey T. Jr. | Principal Accounting Officer | S - Sale+OE | $3.90 | -36,647 | 8,353 | -81% | -$142,959 | |||||
2026-11-03 | FATE | Fate Therapeutics Inc | Adawi Kamal | CFO | S - Sale | $2.05 | -6,582 | 93,418 | -7% | -$13,525 | ||||||
2026-10-20 | FRMI | Fermi Inc. | Neugebauer Toby R | 10% | S - Sale | $3.04 | -420,749 | 142,048,086 | 0% | -$1,277,226 | ||||||
| M | 2026-11-03 | FRMI | Fermi Inc. | Neugebauer Toby R | 10% | S - Sale | $1.70 | -7,657,800 | 92,313,010 | -8% | -$13,018,356 | |||||
2026-11-03 | GRAB | Grab Holdings Ltd | Ong Chin Yin | Chief Org Capability Officer | S - Sale | $3.21 | -38,000 | 3,556,611 | -1% | -$121,980 | ||||||
| D | 2026-11-06 | GRAB | Grab Holdings Ltd | Tan Anthony Ping Yeow | CEO | S - Sale+OE | $3.51 | -800,000 | 10,778,498 | -7% | -$2,808,800 | |||||
| M | 2026-11-12 | GRAB | Grab Holdings Ltd | Kandal Philipp Wolfgang Josef | Chief Product Officer | S - Sale | $3.27 | -150,000 | 3,778,735 | -4% | -$489,906 | |||||
2026-11-12 | GRAB | Grab Holdings Ltd | Ong Chin Yin | Chief Org Capability Officer | S - Sale | $3.28 | -28,000 | 3,528,611 | -1% | -$91,700 | ||||||
2026-11-16 | GRAB | Grab Holdings Ltd | Oey Peter Henry | CFO | S - Sale | $3.22 | -50,000 | 6,703,470 | -1% | -$161,205 | ||||||
| M | 2026-11-11 | HCAT | Health Catalyst, Inc. | Landry Benjamin | GC | S - Sale | $1.42 | -99,478 | 251,894 | -28% | -$140,974 | |||||
2026-11-09 | HNST | Honest Company, Inc. | Sternweis Thomas | SVP, Enterprise Dev., Strat. | S - Sale | $4.70 | -25,000 | 379,394 | -6% | -$117,500 | ||||||
| M | 2026-10-01 | IBATF | International Battery Metals Ltd. | Encompass Capital Advisors LLC | 10% | S - Sale | $0.06 | -520,000 | 57,377,081 | -1% | -$31,200 | |||||
| D | 2026-11-09 | INDI | Indie Semiconductor, Inc. | Wu Naixi | CFO | S - Sale+OE | $2.05 | -33,333 | 196,606 | -14% | -$68,433 | |||||
2026-10-23 | IRD | Opus Genetics, Inc. | Magrath George | CEO | S - Sale | $3.59 | -9,591 | 2,038,894 | 0% | -$34,384 | ||||||
2026-10-23 | IRD | Opus Genetics, Inc. | Gagnon Robert E. | CFO | S - Sale | $3.55 | -14,000 | 542,375 | -3% | -$49,650 | ||||||
2026-10-23 | IRD | Opus Genetics, Inc. | Yerxa Benjamin R | Pres | S - Sale | $3.54 | -33,189 | 670,917 | -5% | -$117,365 | ||||||
2026-10-23 | IRD | Opus Genetics, Inc. | Schachle Joseph K | COO | S - Sale | $3.57 | -4,767 | 286,673 | -2% | -$16,994 | ||||||
2026-11-03 | IRD | Opus Genetics, Inc. | Magrath George | CEO | S - Sale | $3.90 | -28,258 | 2,010,636 | -1% | -$110,184 | ||||||
| M | 2026-11-06 | IRS | Irsa Investments & Representations Inc | Elsztain Alejandro Gustavo | Dir | S - Sale | $1.25 | -98,971 | 5,069,610 | -2% | -$124,103 | |||||
2026-11-16 | IRWD | Ironwood Pharmaceuticals Inc | Gaskins Tammi L | Chief Commercial Officer | S - Sale | $4.81 | -5,919 | 344,431 | -2% | -$28,470 | ||||||
2026-11-04 | JELD | Jeld-Wen Holding, Inc. | Turtle Creek Asset Management Inc. | 10% | S - Sale | $1.16 | -300,000 | 16,325,557 | -2% | -$347,850 | ||||||
2026-11-02 | JOBY | Joby Aviation, Inc. | Sciarra Paul Cahill | Dir | S - Sale | $4.97 | -62,500 | 55,794,801 | 0% | -$310,625 | ||||||
2026-11-13 | KDK | Kodiak Ai, Inc. | Datta Surajit | CFO | S - Sale | $1.04 | -89,440 | 890,985 | -9% | -$93,286 | ||||||
| M | 2026-11-10 | KLTR | Kaltura Inc | Nexus India Capital II LP | 10% | S - Sale | $1.57 | -58,567 | 15,995,290 | 0% | -$92,186 | |||||
| D | 2026-11-03 | LAES | Sealsq Corp | Enguent Jean-Pierre | VP, R, DSS | S - Sale+OE | $1.38 | -35,000 | 0 | -100% | -$48,328 | |||||
2026-10-29 | LENZ | Lenz Therapeutics, Inc. | Ra Capital Management, L.P. | 10% | S - Sale | $3.36 | -2,718,684 | 57,559 | -98% | -$9,134,778 | ||||||
2026-11-12 | LFVN | Lifevantage Corp | Beindorff Michael A | Dir | S - Sale | $4.89 | -10,000 | 82,709 | -11% | -$48,861 | ||||||
2026-10-19 | LHAI | Linkhome Holdings Inc. | Us Innovation Foundation | 10% | S - Sale | $0.53 | -3,020,000 | 800,000 | -79% | -$1,599,775 | ||||||
2026-11-06 | LUCK | Lucky Strike Entertainment Corp | Harinstein Jason | Dir | S - Sale | $3.86 | -13,000 | 0 | -100% | -$50,180 | ||||||
2026-11-17 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO | S - Sale | $3.26 | -3,295 | 373,483 | -1% | -$10,742 | ||||||
2026-11-17 | LZ | Legalzoom.Com, Inc. | Miller Nicole | GC | S - Sale | $4.81 | -32,914 | 864,452 | -4% | -$158,316 | ||||||
2026-11-06 | MX | Magnachip Semiconductor Corp | Amoruso Cristiano | Dir | S - Sale | $2.22 | -378,252 | 3,337,593 | -10% | -$840,665 | ||||||
2026-10-20 | NXDR | Nextdoor Holdings, Inc. | Kiernan Michael | Chief Revenue Officer | S - Sale | $2.54 | -50,000 | 455,917 | -10% | -$127,170 | ||||||
| D | 2026-11-13 | NXDR | Nextdoor Holdings, Inc. | Varelas Christopher | Dir | S - Sale+OE | $2.01 | -216,530 | 0 | -100% | -$434,360 | |||||
2026-11-16 | OM | Outset Medical, Inc. | Trigg Leslie | Chair, CEO | S - Sale | $3.67 | -3,403 | 233,444 | -1% | -$12,489 | ||||||
2026-11-16 | OM | Outset Medical, Inc. | Gaeta Renee | CFO | S - Sale | $3.67 | -4,498 | 176,342 | -2% | -$16,508 | ||||||
2026-11-05 | OPK | Opko Health, Inc. | Paganelli John A | Dir | S - Sale | $1.81 | -13,601 | 389,914 | -3% | -$24,577 | ||||||
2026-11-04 | PACK | Ranpak Holdings Corp. | Tranen Alicia M. | Dir | S - Sale | $3.17 | -5,903 | 772,422 | -1% | -$18,697 | ||||||
2026-10-30 | PLBY | Playboy, Inc. | Fig Buyer Gp, LLC | 10% | S - Sale | $1.05 | -4,761,905 | 85,328 | -98% | -$5,000,000 | ||||||
2026-10-30 | PLBY | Playboy, Inc. | Drawbridge Special Opportunities Fund LP | 10% | S - Sale | $1.05 | -4,761,905 | 85,328 | -98% | -$5,000,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |